Evaluation of catecholamine metabolites, mIBG scan, and bone marrow cytology as response markers in stage 4 neuroblastoma

Medical and Pediatric Oncology

Volumn 36, Issue 1, 2001, Pages 220-223

  Orlando, Claudio ^a   Raggi, Claudia Casini ^a   Bagnoni, Letizia ^a   Sestini, Roberta ^a   Briganti, Vittorio ^b   Cava, Giuseppe La ^a   Bernini, Gabriella ^a   Tonini, Gianpaolo ^a   Pazzagli, Mario ^a   Serio, Mario ^a   Maggi, Mario ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b G GASLINI INSTITUTE   (Italy)

Author keywords

Bone marrow cytology; Catecholamine metabolites; Disseminated neuroblastoma; Homovanillic acid; mIBG scan; Response to therapy; Vanilmandelic acid

Indexed keywords

BIOLOGICAL RESPONSE MODIFIER; HOMOVANILLIC ACID; TUMOR MARKER; VANILMANDELIC ACID;

ACUTE LYMPHOBLASTIC LEUKEMIA; ASPIRATION BIOPSY; BLOOD SAMPLING; BONE MARROW CELL; BRAIN SCINTISCANNING; CANCER STAGING; CANCER SURVIVAL; CATECHOLAMINE METABOLISM; CONFERENCE PAPER; CYTOLOGY; HUMAN; HUMAN CELL; NEUROBLASTOMA; OUTCOMES RESEARCH; PRIORITY JOURNAL; URINARY EXCRETION;

3-IODOBENZYLGUANIDINE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW EXAMINATION; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DACARBAZINE; DISEASE-FREE SURVIVAL; DOXORUBICIN; ETOPOSIDE; HOMOVANILLIC ACID; HUMANS; IFOSFAMIDE; IODINE RADIOISOTOPES; LIFE TABLES; MELPHALAN; NEOPLASM STAGING; NEUROBLASTOMA; RADIOPHARMACEUTICALS; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; VANILMANDELIC ACID; VINCRISTINE; VINDESINE;

EID: 0035174255     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-911X(20010101)36:1<220::AID-MPO1053>3.0.CO;2-6     Document Type: Conference Paper

References (6)

1. Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83.)
2. Neuroblastom
3. Mass fragmentographic determination of homovanillic and 4-hydroxy-3-methoxy mandelic acids in 50 μl plasma
4. Effect of age on homovanillic and 4-hydroxy-3-methoxymandelic acid levels in plasma
5. A new 1231-mIBG whole body scan scoring method - Application to the prediction of the response of metastases to induction chemotherapy in stage 4 neuroblastoma
6. Clinical significance of catecholamine excretion levels in diagnosis and treatment of neuroblastoma